View in EDS HTML Full Text PDF Full Text

Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia.

Saved in:
Bibliographic Details
Title: Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia.
Authors: Parrondo, Ricardo D.1 (AUTHOR), Paulus, Aneel1 (AUTHOR), Alegria, Victoria1 (AUTHOR), Liebowitz, David2 (AUTHOR), Johnson, Chelsea2 (AUTHOR), Clynes, Raphael2 (AUTHOR), Roy, Vivek1 (AUTHOR), Menke, David M.3 (AUTHOR), Jiang, Liuyan3 (AUTHOR), Chanan-Khan, Asher A.1 (AUTHOR), Ailawadhi, Sikander1 (AUTHOR)
Source: Leukemia & Lymphoma. Mar2022, Vol. 63 Issue 3, p738-742. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2021.2005045